Eat #fibre helps #rheumatoid #arthritis! #RCT #RA w #MTX Adding #super fibre Mean #DAS28 3.8 7TJC, SJC2 Small N +RCT
Eat #fibre helps #rheumatoid #arthritis! #RCT #RA w #MTX Adding #super fibre Mean #DAS28 3.8 7TJC, SJC2 Small N +RCT […]
RheumNow
RheumNow
ADA-biosimilar use surged just before CVS formulary change then dropped sharply after. In RISE data, uptake reached 25%
ADA-biosimilar use surged just before CVS formulary change then dropped sharply after. In RISE data, uptake reached 25% https://pbs.twimg.com/profile_images/1525262133575012354/Lfut18gD_normal.jpg john+RNV2@john…
RheumNow
A post-hoc analysis from the ReFlaP study showed that there was a significant correlation between PsAID12 & HAQ scor
A post-hoc analysis from the ReFlaP study showed that there was a significant correlation between PsAID12 & HAQ scor https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN_normal.jpg
Rheumatology
Rheumatology students should ‘take caution’ when using AI, LLMs
CHICAGO — Medical board-style questions created by AI and large language models were often grammatically correct but factually inaccurate, according
Google News
Study Finds NSAIDs May Be Safe in Select IBD Patients – MPR – eMPR.com
… Rheumatology (ACR) Convergence 2025. To better understand the impact of NSAID use in this patient population, researchers used claims
RheumNow
#0852 LEVI-04, a novel p75NTR-Fc fusion protein, significantly reduces MRI bone marrow lesions in knee #OA 🦵📉 Phas
#0852 LEVI-04, a novel p75NTR-Fc fusion protein, significantly reduces MRI bone marrow lesions in knee #OA 🦵📉 Phas https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john…
RheumNow
@JYazdanyMD in the #ACR25 Great AI Debate details out three key risks of AI in rheumatology: – bias at scale – erosion o
@JYazdanyMD in the #ACR25 Great AI Debate details out three key risks of AI in rheumatology: – bias at scale
RheumNow
In this ph2 trial of LEVI-04 for knee #osteoarthritis, At wk 20, LEVI-04 ⬇️ bone marrow lesions (BML), greater ⬇
In this ph2 trial of LEVI-04 for knee #osteoarthritis, At wk 20, LEVI-04 ⬇️ bone marrow lesions (BML), greater ⬇
RheumNow
Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs 2. M
Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs
RheumNow
In the #ACR25 Great AI Debate, @RADoctor and @JYazdanyMD prepared independently, but in consecutive moments agree (in a
In the #ACR25 Great AI Debate, @RADoctor and @JYazdanyMD prepared independently, but in consecutive moments agree (in a https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg john+RNV2@john…
RheumNow
The CLASSIC study (n=1015, 27 countries) validated revised ASAS-SPARTAN axSpA criteria. Final model achieved 79.5% sensi
The CLASSIC study (n=1015, 27 countries) validated revised ASAS-SPARTAN axSpA criteria. Final model achieved 79.5% sensi https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john… Mon, 10/27/2025
RheumNow
#0853 Olink proteomics in anti-Ro+ pregnancies identifies macrophage-derived IL-6 & CCL3 as serum predictors of foet
#0853 Olink proteomics in anti-Ro+ pregnancies identifies macrophage-derived IL-6 & CCL3 as serum predictors of foet https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon, 10/27/2025
RheumNow
#1627 SLR informing the 2025 @eular_org recommendations for PMR & LVV 🔍 141 studies (30 RCTs) reviewed: new &
#1627 SLR informing the 2025 @eular_org recommendations for PMR & LVV 🔍 141 studies (30 RCTs) reviewed: new & https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg
RheumNow
#0854 @Official_ASAS & @SPARTAN_Updates revised #axSpA criteria meet targets: Sn 79.5% / Sp 90.4%. Imaging is centr
#0854 @Official_ASAS & @SPARTAN_Updates revised #axSpA criteria meet targets: Sn 79.5% / Sp 90.4%. Imaging is centr https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon,
RheumNow
Summary of (some) drugs in the pipeline for management of PAH. Slide credits: Dr Benjamin Freed @RheumNow #ACR2025
Summary of (some) drugs in the pipeline for management of PAH. Slide credits: Dr Benjamin Freed @RheumNow #ACR2025 https://pbs.twimg.com/profile_images/1798008672708169728/8cvULQ3I_normal.jpg john+RNV2@john…
Google News
Opioid Overprescribing Seen in Older Patients With Rheumatic Diseases | MedPage Today
Clinical and Medicare records for more than 40,000 patients seen at U.S. rheumatology clinics in 2021 showed that 43.3% received
Opioid Overprescribing Seen in Older Patients With Rheumatic Diseases
(MedPage Today) — CHICAGO — Urgent advice to prescribe alternatives to opioid painkillers doesn’t seem to be getting through to
Google News
Survey Reveals Factors Tied to CAM Use in Patients With Rheumatic Diseases – eMPR.com
The most common rheumatic disease reported was rheumatoid arthritis (58%), followed by Sjögren disease (19%). CAM usage was found to
Google News
Duloxetine vs Pregabalin: Outcomes in Fibromyalgia Patients Compared – MPR – eMPR.com
… Rheumatology (ACR) Convergence 2025. A retrospective cohort study was conducted using data from the TriNetX Global Collaborative Network to …
Google News
Rheumatology and artificial intelligence: The time is now – Healio
I recently had the privilege of speaking at the Advances in Rheumatology and Technologies Symposium (ARTS), held in Chicago on
RheumNow
🎥 LIVE from #ACR25 Join us daily at 5 PM CST for RheumNow’s ACR Recap Live – Your must-watch debrief of the day’
🎥 LIVE from #ACR25 Join us daily at 5 PM CST for RheumNow’s ACR Recap Live – Your must-watch debrief
Early Peripheral SpA: Is it okay to stop treatment sometimes?
Early Peripheral SpA: Is it okay to stop treatment sometimes? tammytilley@gm… Mon, 10/27/2025 – 09:52 Spondyloarthritis Dr. Richard Conway reports
RheumNow
In a global retrospective study of 90,536 PsA patients, those on GLP-1 receptor agonists (n=4,104) had significantly low
In a global retrospective study of 90,536 PsA patients, those on GLP-1 receptor agonists (n=4,104) had significantly low https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john…
RheumNow
Time for the 2nd plenary session! 🎤 #0849 GLP-1 receptor agonists in #PsA linked with lower mortality & fewer maj
Time for the 2nd plenary session! 🎤 #0849 GLP-1 receptor agonists in #PsA linked with lower mortality & fewer maj
RheumNow
This morning in the plenary, same theme, but in PsA: Similar metabolic/CV concerns Similarly benefit from GLP-1 RA look
This morning in the plenary, same theme, but in PsA: Similar metabolic/CV concerns Similarly benefit from GLP-1 RA look https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg
RheumNow
GLP-1 RA meds: we are just starting to see their impact in rheumatoid arthritis. We know metabolic, CV risk in RA, but w
GLP-1 RA meds: we are just starting to see their impact in rheumatoid arthritis. We know metabolic, CV risk in
Catching AxSpA Early: Closing the Diagnostic Gap
Catching AxSpA Early: Closing the Diagnostic Gap tammytilley@gm… Mon, 10/27/2025 – 09:20 Spondyloarthritis Labs/Biomarkers Dr. Akhil Sood reports on abstract